Cellular Intelligence competitors & alternatives

BlueRock TherapeuticsBiotechnologyUnited States

69% match

Biotechnology

BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.

Aspen NeuroscienceBiotechnologyUnited States

68% match

Biotechnology

Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.

Logic BioBiotechnology

68% match

Biotechnology

FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.

NEURONA THERAPEUTICS INCBiotechnologyUnited States

68% matchPrivate

Biotechnology

Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.

NeumirnaBiotechDenmark

67% match

Similar biotech company

Neumirna Therapeutics is a biotechnology company founded in 2021 and headquartered in Copenhagen, Denmark. The firm is dedicated to pioneering RNA-based therapies to treat epilepsy, Parkinson's disease, and other neurological disorders.

Biotechnology

NeuroInitiative is a computational biology company that uses a patented AI simulation platform to identify and prioritize drug targets for neurodegenerative and age-related diseases. The company develops therapeutic pipelines, such as its spinout Vincere Biosciences, focusing on treatments for conditions like Parkinson's disease.

Biotechnology

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.

CellarityBiotechUnited States

66% match

Similar biotech company

Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.

cTRL TherapeuticsBiotechnologyUnited States

66% match

Biotechnology

cTRL Therapeutics is a biotechnology research company headquartered in Chicago, Illinois, United States, focused on innovative cellular science and therapeutics.

CuraSen Therapeutics, Inc.BiotechnologyUnited States

66% matchPrivate

Biotechnology

CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.

Endurance Biotech, Inc.BiotechnologyUnited States

66% matchPrivate

Biotechnology

Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.

Similar biotech company

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.